New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
LFSC ETF · F/m Emerald Life Sciences Innovation ETF
The LFSC Exchange Traded Fund (ETF) is provided by Emerald Group. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofLife Sciences1M perf.-5.68%
Last price
$33.61
1M perf.
-5.63%
1M flows
+€5M
AuM
€78M
E/R
0.79%
Rating
Not rated
ESG Consensus®
LFSC
$33.61
Performance & flows
Segment for quartile rank
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
LFSC
$33.64
-12.79%
Life Sciences
-12.79%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.63% | -12.79% | +50.10% | N/A | N/A | -7.61% | -8.11% | -8.11% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/13/2026
$33.64
1D NAV change
-0.59%
Dividend policy
No. of holdings
42
Inception date
10/31/2024
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust (the “Sub-Adviser”)
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
PSCH
1M perf.
-6.23%
E/R
0.29%
ARKG
1M perf.
-3.62%
E/R
0.75%
AAKG
1M perf.
-5.74%
E/R
0.75%
PTH
1M perf.
-1.98%
E/R
0.72%
XBI
1M perf.
-0.80%
E/R
0.35%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -12.79% | +50.10% | N/A | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
88.44%
United Kingdom
6.76%
Singapore
4.81%
Sectors
Health Care
86.26%
Unavailable
13.13%
Other
0.61%
Diversification
Total weight of top 15 holdings out of 42
Top 15 holdings
Data as of January 31, 2026
COGENT BIOSCIENCES
LIVANOVA
GUARDANT HEALTH INC
MIRUM PHARMACEUTICALS INC
TRANSMEDICS GROUP
WAVE LFE SCIEN
TRAVERE THERAPEUTICS INC
BRIDGEBIO PHARMA
Create a free account to view top holdings
SAVARA INC
ICU MEDICAL
KALVISTA PHARMACEUTICALS INC
UTD THERAPEUT
US00773J2024
MADRIGAL PHARMACEUTICALS INC
ACADIA PHARMACEUTICALS
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Emerald Group
Emerald Group ID Card
Number of funds
2
Total AuM
€98M
Expense ratio range
0.79% - 0.89%
Average expense ratio
0.84%
Top 2 funds by Emerald Group
| AuM | ||
|---|---|---|
LFSC | F/m Emerald Life Sciences Innovation ETF | €78M |
SPIT | F/m Emerald Special Situations ETF | €20M |
Frequently asked questions about LFSC
What does F/m Emerald Life Sciences Innovation ETF, LFSC, invest in?
LFSC is a Active ETF. This ETF provides exposure to Other Mid and Small-Cap Equities.
What is the Total Expense ratio (TER) of LFSC?
LFSC carries a total expense ratio (TER) of 0.79%, indicating the annual cost for holding the fund.
When was LFSC launched?
LFSC was introduced to the market on October 31, 2024. It trades on United States
Who is the ETF issuer of LFSC?
F/m Emerald Life Sciences Innovation ETF, LFSC, is provided by Emerald Group. Learn more about Emerald Group here.
What is the current assets under management (AUM) of LFSC?
LFSC oversees €78M in assets as of March 13, 2026.
How has LFSC performed lately?
Based on data from March 13, 2026, LFSC returned -5.63% over the past month, -12.79% over the last three months and -8.11% year-to-date.
What are the latest inflows or outflows for LFSC?
As of March 13, 2026, LFSC recorded net flows of +€4.9M over the last month and +€4.4M year-to-date.
Does LFSC distribute dividends?
LFSC follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of LFSC?
As of January 31, 2026, LFSC has significant geographic allocations in USA, United Kingdom and Singapore.
In which sector or theme does LFSC invest in?
As of January 31, 2026, LFSC focuses largely on Health Care.
How many securities does LFSC hold and how diversified is it?
As of January 31, 2026, LFSC holds 42 positions in its portfolio, with 68.94% of assets concentrated in its top 15 holdings.
What are the main positions in LFSC?
As of January 31, 2026, LFSC top three holdings include COGENT BIOSCIENCES, LIVANOVA and GUARDANT HEALTH INC.
What is the base currency of LFSC?
The base currency of LFSC is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
